Chief Executive appointed to senior international industry position

Medicines Australia announced today that its Chief Executive, Dr Brendan Shaw, had been appointed to a senior position within the global pharmaceutical industry.

Medicines Australia Chairman, Dr Martin Cross, congratulated Dr Shaw on his appointment.

“While I am not able to discuss the specifics, the news that Brendan has been appointed to a senior international position is a great step forward for Brendan in his career and recognition of the work he and Medicines Australia have done over the years,” Dr Cross said.

“While obviously challenging for Medicines Australia, the Board recognises this is a great opportunity for Brendan, fully supports his appointment and wishes him well for the future.

“We look forward to continuing our association with Brendan and working with him in the future.”

Dr Shaw said he was looking forward to his new role but would be sad to be leaving Medicines Australia.

“This is a great industry full of great people. It has been a genuine privilege to work with and serve the people that make up the Australian medicines industry,” Dr Shaw said.

“This industry and the medicines and vaccines it develops are so important for the community. It’s due to this industry that we have medicines and vaccines today that save lives and treat disease.

“The good news is that my new role will allow me to stay in touch with the pharmaceutical industry.”

Dr Shaw will finish his role as Medicines Australia Chief Executive on 12 September to take up his new position later this year. He will be serving on full duties as Chief Executive up to his departure day on 12 September.

Dr Cross also confirmed that the Board of Medicines Australia had already begun a search process to find a new Chief Executive for Medicines Australia.

“This is an important time for the Australian medicines industry, with a number of major challenges but also incredible opportunities, so we’ve started looking for a strong candidate to take up the baton when Brendan departs,” Dr Cross said.


Contact Person:

Elizabeth de Somer
Phone: 04108 774 596